SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-20-004348
Filing Date
2020-02-19
Accepted
2020-02-19 18:41:18
Documents
2
Period of Report
2020-02-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 4323
2 POWER OF ATTORNEY kavanaughpoa.htm EX-24.1 7756
  Complete submission text file 0001567619-20-004348.txt   13481
Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Issuer) CIK: 0001501989 (see all company filings)

IRS No.: 273521219 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O FIVE PRIME THERAPEUTICS, INC. TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080
Business Address
Kavanaugh William Michael (Reporting) CIK: 0001578767 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37587 | Film No.: 20631821